Asia & Pacific

NZ Class Action Filed Against Johnson & Johnson Alleging Cold, Flu Medicines Ineffective

The lawsuit also claims Johnson & Johnson knew a key drug in its medicines did not work.
NZ Class Action Filed Against Johnson & Johnson Alleging Cold, Flu Medicines Ineffective
The Johnson & Johnson logo is displayed at company offices in Irvine, California on Oct. 17, 2023. Mario Tama/Getty Images
Rex Widerstrom
|Updated:
0:00

Pharmaceutical giant Johnson & Johnson is facing one of New Zealand’s largest ever class actions alleging the company sold ineffective cold and flu medicines.

At issue are popular brands marketed in New Zealand under the names Codral, Benadryl, Day & Night, and Sudafed, which contain a substance called phenylephrine or PE.

Rex Widerstrom
Rex Widerstrom
Author
Rex Widerstrom is a New Zealand-based reporter with over 40 years of experience in media, including radio and print. He is currently a presenter for Hutt Radio.